Effects of steroid exposure on ligand binding and functional activities of diverse nicotinic acetylcholine receptor subtypes

Journal of Neurochemistry

Volumn 67, Issue 3, 1996, Pages 1100-1112

  Ke, Lei ^a   Lukas, Ronald J ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Acetylcholine; Nicotine; Nicotinic receptor; Progesterone; Steroid

Indexed keywords

CORTICOSTERONE; DEXAMETHASONE; ESTRADIOL; LIGAND; NEUROTRANSMITTER RECEPTOR; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; STEROID;

ACETYLCHOLINE RELEASE; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIGAND BINDING; NEUROBLASTOMA CELL; NEUROSECRETION; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN POLYMORPHISM; SIGNAL TRANSDUCTION; STRESS;

BOVINAE;

EID: 0029825054     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67031100.x     Document Type: Article

References (53)

1. Abadji V., Raines D. E., Dalton L. A., and Miller K. W. (1994) Lipid-receptor interactions and protein dynamics in vesicles containing the nicotinic acetylcholine receptor: a study with ethanol. Biochim. Biophys. Acta 1194, 25-34.
2. Alkondon M. and Albuquerque E. X. (1993) Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J. Pharmacol. Exp. Ther. 265, 1455-1473.
3. Arimatsu Y., Seto A., and Amano T. (1981) Sexual dimorphism in α-bungarotoxin binding capacity in the mouse amygdala. Brain Res. 213, 432-437.
4. Barrantes F. J. (1993) Structural-functional correlates of the nicotinic acetylcholine receptor and its lipid microenvironment. FASEB J. 7, 1460-1467.
5. Baulieu E. E. (1991) Neurosteroids: a new function in the brain. Biol. Cell 71 3-10.
6. Bencherif M. and Lukas R. J. (1993) Cytochalasin modulation of nicotinic cholinergic receptor expression and muscarinic receptor function in human TE671/RD cells: a possible functional role of the cytoskeleton. J. Neurochem. 61, 852-864.
7. Bencherif M., Eisenhour C. M., Prince R. J., Lippiello P. M., and Lukas R. J. (1995) The "calcium antagonist" TMB-8 [3,4,5-trimethoxy benzoic acid 8-(diethylamino) octyl ester] is a potent, non-competitive, functional antagonist at diverse nicotinic acetylcholine receptor subtypes. J. Pharmacol. Exp. Ther. 275, 1418-1426.
8. Bergeron R., de Montigny C., and Debonnel G. (1996) Potentiation of neuronal NMDA response induced by dehydroepiandosterone and its suppression by progesterone: effects mediated via sigma receptors. J. Neurosci. 16, 1193-1202.
9. Bertrand D., Valera S., Bertrand S., Ballivet M., and Rungger D. (1991) Steroids inhibit nicotinic acetylcholine receptors. Neuroreport 2, 277-280.
10. Bowlby M. R. (1993) Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. Mol. Pharmacol. 43, 813-819.
11. Braun S., Askanas V., Engel W. K., and Ibrahim E. N. (1993) Long-term treatment with glucocorticoids increases synthesis and stability of junctional acetylcholine receptors on innervated cultured human muscle. J. Neurochem. 60, 1929-1935.
12. Changeux J.-P., Galzi J.-L., Devillers-Thiery A., and Bertrand D. (1992) The functional architecture of the acetylcholine receptor explored by affinity labeling and site directed mutagenesis. Q. Rev. Biophys. 25, 395-432.
13. Collins A. C., Baht R. V., Pauly J. R., and Marks M. J. (1990) Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists. Ciba Found. Symp. 152, 68-82.
14. A receptor activity by alphaxalone. Br. J. Pharmacol. 90, 491-500.
15. Devleeschouwer N., Body J. J., Legros N., Muquardt C., Donnay I., Wouters P., and Leclercq G. (1992) Growth factor-like activity of phenol red preparations in the MCF-7 breast cancer cell line. Anticancer Res. 12, 789-794.
16. Fernandez A. M., Fernandez-Ballester G., Ferragut J. A., and Gonzalez-Ros J. M. (1993) Labeling of the nicotinic acetylcholine receptor by a photoactivatable steroid probe: effects of cholesterol and cholinergic ligands. Biochim. Biophys. Acta 1149, 135-144.
17. Flores C. M., Rogers S. W., Pabreza L. A., Wolfe B. B., and Kellar K. J. (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. Mol. Pharmacol. 41, 31-37.
18. Gillo B. and Lass Y. (1984) The mechanism of steroid anesthetic (alphaxalone) block of acetylcholine-induced ionic currents. Br. J. Pharmacol. 82, 783-789.
19. Hart M. V., Hosenpud J. D., Hohimer A. R., and Motion M. J. (1985) Hemodynamics during pregnancy and sex steroid administration in guinea pigs. Am. J. Physiol. 249, R179-R185.
20. Ichikawa S., Sawada T., Nakamura Y., and Morioka H. (1974) Ovarian secretion of pregnane compounds during the estrous cycle and pregnancy in rats. Endocrinology 94, 1615-1620.
21. Inoue M. and Kuriyama H. (1989) Glucocorticoids inhibit acetylcholine-induced current in chromaffin cells. Am. J. Physiol. 257, c906-c912.
22. 2+ in cultured hippocampal neurons. Neurosci. Lett. 141, 30-34.
23. 2+ responses: structure-activity studies. J. Pharmacol. Exp. Ther. 271, 677-682.
24. Kaplan I., Blakely B. T., Pavlath G. K., Travis M., and Blau H. M. (1990) Steroids induce acetylcholine receptors on cultured human muscle: implications for myasthenia gravis. Proc. Natl. Acad. Sci. USA 87, 8100-8104.
25. Ke L. and Lukas R. J. (1994) Effects of steroid exposure on ligand binding and functional activity of nicotinic acetylcholine receptors. Soc. Neurosci. Abstr. 20, 1136.
26. A receptor function. Trends Pharmacol. Sci. 16, 295-303.
27. Lukas R. J. (1984) Properties of curaremimetic neurotoxin binding sites in the rat central nervous system. Biochemistry 23, 1152-1160.
28. Lukas R. J. (1986a) Characterization of curaremimetic neurotoxin binding sites on membrane fractions derived from the human medulloblastoma clonal line, TE671. J. Neurochem. 46, 1936-1941.
29. Lukas R. J. (1986b) Immunochemical and pharmacological distinctions between curaremimetic neurotoxin binding sites of central, autonomic, and peripheral origin. Proc. Natl. Acad. Sci. USA 83, 5741-5745.
30. Lukas R. J. (1989) Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and TE671 human medulloblastoma. J. Pharmacol Exp. Ther. 251, 175-182.
31. 3H]-acetylcholine binding sites. J. Pharmacol. Exp. Ther. 253, 51-57.
32. Lukas R. J. (1991) Effects of chronic nicotinic ligand exposure on functional activity of nicotinic acetylcholine receptors expressed by cells of the PC12 rat pheochromocytoma or the TE671/RD human clonal line. J. Neurochem. 56, 1134-1145.
33. Lukas R. J. (1995) Diversity and patterns of regulation of nicotinic receptor subtypes. Ann. NY Acad. Sci. 757, 153-168.
34. Lukas R. J. and Bencherif M. (1992) Heterogeneity and regulation of nicotinic acetylcholine receptors. Int. Rev. Neurobiol. 34, 25-131.
35. Lukas R. J. and Cullen M. J. (1988) An isotopic rubidium ion efflux assay for the functional characterization of nicotinic acetylcholine receptors on clonal cell lines. Anal. Biochem. 175, 212-218.
36. Lukas R. J., Norman S. A., and Lucero L. (1993) Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line. Mol. Cell. Neurosci. 4, 1-12.
37. Majewska M. D. and Schwartz R. D. (1987) Pregnenolone sulfate: an endogenous antagonist of the γ-amino butyric acid receptor complex in brain. Brain Res. 404, 355-360.
38. A receptor. Eur. J. Pharmacol. 189, 307-315.
39. Mandler R, N., Seamer L. C., Domalewski M. D., and Bankhurst A. D. (1993) Progesterone but not estrogen depolarizes natural killer cells. Nat. Immun. 12, 128-135.
40. McCauley L. D., Liu V., Chen J. S., Hawkinson J. E., Lan N. C., and Gee K. W. (1995) Selective actions of certain neuroactive pregnanediols at the gamma-amino butyric acid type A receptor complex in rat brain. Mol. Pharmacol. 47, 354-362.
41. Nguyen Q., Sapp D. W., Van Ness P. C., and Olsen R. W. (1995) Modulation of GABAA receptor binding in human brain by neuroactive steroids: species and brain regional differences. Synapse 19, 77-87.
42. Olsen R. W. and Sapp D. W. (1995) Neuroactive steroid modulation of GABAA receptors. Adv. Biochem. Psychopharmacol. 48, 57-74.
43. Paul S. M. and Purdy R. H. (1992) Neuroactive steroids. FASEB J. 6, 2311-2322.
44. Pauly J. R., Ullman E. A., and Collins A. C. (1988) Adrenocortical hormone regulation of nicotine sensitivity in mice. Physiol. Behav. 44, 109-116.
45. Prince R. J. and Simmonds M. A. (1992) Steroid modulation of the strychnine-sensitive glycine receptor. Neuropharmacologv 31, 201-205.
46. Puchacz E. P., Buisson B., Bertrand D., and Lukas R. J. (1994) Functional expression of nicotinic acetylcholine receptors containing rat α7 subunits in human SH-SY5Y neuroblastoma cells. FEBS Lett. 354, 155-159.
47. Sargent P. B. (1993) The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16, 403-443.
48. Valera S., Ballivet M., and Bertrand D. (1992) Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. USA 89, 9949-9953.
49. Vernallis A. B., Conroy W. G., and Berg D. K. (1993) Neurons assemble acetylcholine receptors with as many as three kinds of subunits while maintaining subunit segregation among receptor subtypes. Neuron 10, 451-464.
50. Whiting P. and Lindstrom J. (1987) Purification and characterization of a nicotinic acetylcholine receptor from rat brain. Proc. Natl. Acad. Sci. USA 84, 595-599.
51. 3H] N-methyl scopolamine) binding in micropunches of rat ventricular myocardium: characterization and modification by progesterone. Can. J. Physiol. Pharmacol. 70, 943-948.
52. Wu F.-S., Gibbs T. T., and Farb D. H. (1990) Inverse modulation of γ-amino butyric acid- and glycine-induced currents by progesterone. Mol. Pharmacol. 37, 597-602.
53. Wu F.-S., Gibbs T. T., and Farb D. H. (1991) Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol. Pharmacol. 40, 333-336.